UnitedHealth's stock dropped 3% after Bloomberg reported the company sold a stake in its Florida WellMed primary-care clinics to TPG. This move comes just hours before UnitedHealth is set to reaffirm its full-year 2026 financial guidance, which could either support or challenge investor confidence. The sale aims to accelerate clinic growth with local support while UnitedHealth continues its operational reset, especially in its Optum Health unit, which had previously caused profit setbacks. Investors will watch closely for management's guidance reaffirmation and any updates on Optum Health's margin improvements and growth targets.
The Schwab US Dividend Equity ETF (SCHD) has delivered strong price returns of 33% over the past year, yet its dividend income has grown only modestly by about 2%. The fund's top holdings, including Qualcomm, Texas Instruments, UnitedHealth, and Coca...
UnitedHealth Group is focused on expanding its operating margins rather than growing revenue, with margins expected to rebound to 7.8–8.0% by 2030. This improvement is driven by repricing strategies, Medicaid rate adjustments, and restructuring withi...
The Schwab U.S. Dividend Equity ETF (SCHD) has grown to nearly $95 billion in assets, attracting retirees with a 3.2% dividend yield from a portfolio of financially strong companies. Its top holdings include Qualcomm, UnitedHealth, Coca-Cola, and Tex...
UnitedHealth Group is initiated with a Strong Buy rating and a $533 price target, suggesting 33% upside from its current price. The positive outlook is driven by margin recovery, Optum Health's move to higher-quality contracts, and AI-enhanced effici...
UnitedHealth Group was downgraded from strong buy to buy because its shares appear fully valued at a 20x forward price-to-earnings ratio. The company reported better-than-expected Q3 earnings with revenue of $112.7 billion and earnings per share of $...
